Urinary soluble CD163 is useful as “liquid biopsy” marker in lupus nephritis at both diagnosis and follow-up to predict impending flares

IF 4.7 Q2 IMMUNOLOGY Journal of Translational Autoimmunity Pub Date : 2024-06-20 DOI:10.1016/j.jtauto.2024.100244
Yves Renaudineau , Dominique Chauveau , Stanislas Faguer , Antoine Huart , David Ribes , Gregory Pugnet , Laurent Sailler , Thibaut Jamme , Emmanuel Treiner , Françoise Fortenfant , Chloé Bost , Caroline Carlé , Julie Belliere
{"title":"Urinary soluble CD163 is useful as “liquid biopsy” marker in lupus nephritis at both diagnosis and follow-up to predict impending flares","authors":"Yves Renaudineau ,&nbsp;Dominique Chauveau ,&nbsp;Stanislas Faguer ,&nbsp;Antoine Huart ,&nbsp;David Ribes ,&nbsp;Gregory Pugnet ,&nbsp;Laurent Sailler ,&nbsp;Thibaut Jamme ,&nbsp;Emmanuel Treiner ,&nbsp;Françoise Fortenfant ,&nbsp;Chloé Bost ,&nbsp;Caroline Carlé ,&nbsp;Julie Belliere","doi":"10.1016/j.jtauto.2024.100244","DOIUrl":null,"url":null,"abstract":"<div><p>Lupus nephritis (LN) diagnosis and follow-up requires noninvasive biomarkers. Therefore, the added value of coupling the urinary soluble (s)CD163/creatinuria ratio with serological markers was evaluated in a real-world clinical practice. To this end, a monocentric and retrospective study was conducted in 139 SLE patients with biopsy-proven nephritis having an active LN (LN-A, n = 63 with a positive SLEDAI-renal score) or inactive (n = 76), as well as 98 non-renal SLE patients. The urinary sCD163/creatinuria ratio outperformed serological markers for predicting LN-A (AUC&gt;0.972; p &lt; 10<sup>−4</sup> with a 100 % specificity threshold fixed at 320 ng/mmol), and for monitoring renal activity allowing prediction of impending flares and remissions in follow-up (AUC = 0.789, p &lt; 10<sup>−4</sup>). LN-A patients with an elevated spot proteinuria/creatinuria ratio (p = 8 × 10<sup>−6</sup>) and sCD163/creatinuria ratio (p = 10<sup>−3</sup>) were at risk for developing end-stage kidney disease but sCD163/creatinuria ratio cannot substitute kidney biopsy to discriminate LN-A from other glomerulonephritis. Among serological markers (n = 14), anti-dsDNA and anti-C1q antibodies (Abs) (AUC&gt;0.750 versus non-LN patients, and AUC&gt;0.640 versus LN-IR patients) best predicted LN-A, and higher levels were retrieved in class III/IV proliferative LN-A. In multivariate logistic regression analysis, the urinary sCD163/creatinuria ratio remained the only statistically significant biomarker to predict LN-A (p &lt; 0.001). In conclusion, and as compared to classical serological markers, the urinary sCD163/creatinuria ratio provides an additional parameter for monitoring LN patients.</p></div>","PeriodicalId":36425,"journal":{"name":"Journal of Translational Autoimmunity","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589909024000145/pdfft?md5=5f6c05181e41d12b1f58ed7baadf5037&pid=1-s2.0-S2589909024000145-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Translational Autoimmunity","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589909024000145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Lupus nephritis (LN) diagnosis and follow-up requires noninvasive biomarkers. Therefore, the added value of coupling the urinary soluble (s)CD163/creatinuria ratio with serological markers was evaluated in a real-world clinical practice. To this end, a monocentric and retrospective study was conducted in 139 SLE patients with biopsy-proven nephritis having an active LN (LN-A, n = 63 with a positive SLEDAI-renal score) or inactive (n = 76), as well as 98 non-renal SLE patients. The urinary sCD163/creatinuria ratio outperformed serological markers for predicting LN-A (AUC>0.972; p < 10−4 with a 100 % specificity threshold fixed at 320 ng/mmol), and for monitoring renal activity allowing prediction of impending flares and remissions in follow-up (AUC = 0.789, p < 10−4). LN-A patients with an elevated spot proteinuria/creatinuria ratio (p = 8 × 10−6) and sCD163/creatinuria ratio (p = 10−3) were at risk for developing end-stage kidney disease but sCD163/creatinuria ratio cannot substitute kidney biopsy to discriminate LN-A from other glomerulonephritis. Among serological markers (n = 14), anti-dsDNA and anti-C1q antibodies (Abs) (AUC>0.750 versus non-LN patients, and AUC>0.640 versus LN-IR patients) best predicted LN-A, and higher levels were retrieved in class III/IV proliferative LN-A. In multivariate logistic regression analysis, the urinary sCD163/creatinuria ratio remained the only statistically significant biomarker to predict LN-A (p < 0.001). In conclusion, and as compared to classical serological markers, the urinary sCD163/creatinuria ratio provides an additional parameter for monitoring LN patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
尿液可溶性 CD163 可作为狼疮肾炎的 "液体活检 "标记物,在诊断和随访时预测即将复发的病情
狼疮性肾炎(LN)的诊断和随访需要无创生物标志物。因此,我们在实际临床实践中评估了尿可溶性(s)CD163/肌酐尿比值与血清学标志物相结合的附加值。为此,我们对 139 名经活检证实患有活动性 LN(LN-A,n = 63,SLEDAI-肾脏评分为阳性)或非活动性(n = 76)肾炎的系统性红斑狼疮患者,以及 98 名非肾脏病系统性红斑狼疮患者进行了单中心回顾性研究。在预测LN-A(AUC>0.972; p <10-4,100%特异性阈值固定为320纳克/毫摩尔)和监测肾脏活动方面,尿液sCD163/肌酐尿量比值优于血清学标记物(AUC = 0.789, p <10-4)。斑点蛋白尿/肌酐尿比值升高(p = 8 × 10-6)和 sCD163/肌酐尿比值升高(p = 10-3)的 LN-A 患者有发展为终末期肾病的风险,但 sCD163/肌酐尿比值不能替代肾活检来区分 LN-A 和其他肾小球肾炎。在血清学标记物(n = 14)中,抗dsDNA和抗C1q抗体(Abs)(与非LN患者相比,AUC>0.750;与LN-IR患者相比,AUC>0.640)最能预测LN-A,在III/IV级增生性LN-A中,Abs水平更高。在多变量逻辑回归分析中,尿 sCD163/肌酐尿比值仍是预测 LN-A 的唯一具有统计学意义的生物标志物(p <0.001)。总之,与传统的血清学标志物相比,尿液中的 sCD163/肌酐比值为监测 LN 患者提供了一个额外的参数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Translational Autoimmunity
Journal of Translational Autoimmunity Medicine-Immunology and Allergy
CiteScore
7.80
自引率
2.60%
发文量
33
审稿时长
55 days
期刊最新文献
Autoimmune diseases and cardiovascular risk: Mendelian randomization analysis for the impact of 19 autoimmune diseases on 14 cardiovascular conditions Homeostatic signals, including IL-7 and self-MHC recognition, induce the development of peripheral helper T cells, which are enriched in the joints of rheumatoid arthritis C3 glomerulopathy is highly prevalent in French Polynesia Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for juvenile idiopathic arthritis Association of COVID-19 with Thyroid Dysfunction and Autoimmune Thyroid Disease: A Retrospective Cohort Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1